Novo Nordisk Offers Discount on Ozempic and Wegovy

Why this matters: This discount could make these medications more accessible to a broader range of patients, particularly those without comprehensive insurance coverage.

Novo Nordisk's move to offer discounted prices for Ozempic and Wegovy reflects a broader strategy to increase access to these in-demand medications. The initial $199 monthly cost for the lowest doses is designed to attract new users, while the subsequent increase to $349 may still be more affordable than the standard list prices, which can exceed $1,000 per month.

This pricing strategy is available through the Ozempic and Wegovy websites, where individuals can register for discounts to use at pharmacies and via telehealth services. The company's efforts also include partnerships with retailers like Costco, CVS, and Walmart to provide additional savings opportunities.

However, some experts caution that the "teaser rates" might lead to patients discontinuing the medication once the price increases, potentially negating health benefits. There are concerns this could impact insurance coverage, as employers may seek to reduce spending on employee benefits by leveraging lower cash prices. Despite potential drawbacks, the prevailing view is that this price reduction is a positive step towards enhancing patient access to these medications.

Individuals paying out-of-pocket without insurance coverage.

The 0.25 mg and 0.5 mg injections are available for $199 per month for the first two months, then the price moves to $349 per month including the 1 mg dose of Ozempic and all doses of Wegovy.

Through the Ozempic and Wegovy websites, and at participating pharmacies and retailers like Costco, CVS, and Walmart.

Do you think this discount will significantly improve access to weight loss medications? Share your thoughts in the comments!

Share this article with others who need to stay ahead of this trend!